U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436273) titled 'Development and Validation of a Risk Prediction Model for New-Onset Diabetes After Pancreatectomy' on Feb. 21.
Brief Summary: New-onset diabetes is one of the major complications after pancreatectomy. Without timely diagnosis, treatment and management, it can lead to adverse outcomes such as cardiovascular and cerebrovascular events and severe infections, increasing mortality. Moving the management threshold forward, early risk identification, and precise and effective intervention are the keys to its management.
Existing risk prediction studies show high heterogeneity across different populations and surgical procedures. Risk fact...